Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04659629
Title NL-201 in Patients With Relapsed or Refractory Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Neoleukin Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
Providence Cancer Center Oncology and Hematology Care Clinic Portland Oregon 97213 United States Details
UT- MD Anderson Houston Texas 77230 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Melanoma Institute Australia Sydney New South Wales 2065 Australia Details
St Vincents Hospital Sydney New South Wales Australia Details
Olivia Newton-John Cancer Wellness & Research Centre Heidelberg Victoria Australia Details
UHN - Princess Margaret Cancer Center Toronto Ontario M5G1Z5 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field